Mitsuka To Start As New Tanabe Mitsubishi President From June 20
This article was originally published in PharmAsia News
Executive Summary
Tanabe Mitsubishi Japan has promoted its Managing Director Masayuki Mitsuka to president, the company announced on April 23. Mitsuka will take over activities from current President Michihiro Tsuchiya from June 20 onwards.
Tanabe Mitsubishi Japan has promoted its Managing Director Masayuki Mitsuka to president, the company announced on April 23. Mitsuka will take over activities from current President Michihiro Tsuchiya from June 20 onwards. He entered Mitsubishi Kasei in 1982 after attaining a doctorate from the School of Pharmaceutical Sciences at Tokyo University and became head of Product Strategy at Tanabe Mitsubishi in 2007. During this time he led the development of MS drug fingolimod (Gilenya) and SGLT2 inhibitor canagliflozin (Invokana). The immediate challenge for the company, according to Mitsuka, is the strengthening of the domestic sales force and revenue base as this is Tanabe Mitsubishi`s main source of income. (Click Here For More – Japanese Language
)
“Managing Director Mitsuka To Be President From June 20, Led Gilenya And Canagliflozin Development” - mixonline.jp (4/24/2014)